Ftse Mib
33.746,66
0,00%
DAX
17.921,95
0,00%
S&P 500
5.018,39
-0,34%
NASDAQ Composite
15.605,48
-0,33%
Bitcoin
57.665,13
-0,99%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aileron Therapeutics Inc (ALRN) Aileron Therapeutics Inc (ALRN) Notizie

Aileron Therapeutics Inc

ALRN
4,16
0,00 (0,00%)
02 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
01/5/202414:45GLOBEAileron Therapeutics Announces Pricing of Underwritten..
01/5/202414:30GLOBEAileron Therapeutics Announces Positive Data from Cohort 1..
15/4/202423:20GLOBEAileron Therapeutics Reports Fourth Quarter and Full Year..
12/3/202413:00GLOBEAileron Therapeutics Announces CEO Transition
06/3/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202413:01EDGAR2Form 8-K - Current report
15/2/202422:05GLOBEAileron Therapeutics and Pulmonary Care Experts To Discuss..
13/2/202413:01EDGAR2Form 8-K - Current report
06/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
05/2/202419:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
01/2/202422:30GLOBEAileron Therapeutics to Host Key Opinion Leader Event on..
31/1/202422:05EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/1/202422:15EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/1/202422:10EDGAR2Form S-3 - Registration statement under Securities Act of..
29/1/202414:46EDGAR2Form DEF 14A - Other definitive proxy statements
29/1/202414:14EDGAR2Form 8-K - Current report
25/1/202413:00EDGAR2Form 8-K - Current report
19/1/202422:44EDGAR2Form PRE 14A - Other preliminary proxy statements
11/1/202422:18EDGAR2Form 8-K/A - Current report: [Amend]
10/1/202422:08EDGAR2Form 8-K - Current report
18/12/202323:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202322:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202323:08EDGAR2Form SC 13G - Statement of acquisition of beneficial..
03/11/202301:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202301:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
03/11/202301:47EDGAR2Form 3 - Initial statement of beneficial ownership of..
31/10/202317:40EDGAR2Form 8-K - Current report
31/10/202317:30PRNUSAileron Therapeutics Announces Acquisition of Lung..
13/10/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/8/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apertura: Min: Max:
Chiusura: 4,16

La tua Cronologia

NASDAQ
ALRN
Aileron Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network